OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin–proteasome pathway in ER + breast cancer
Chih-Yi Lin, Chung-Jen Yu, Chun‐Yu Liu, et al.
Clinical & Translational Oncology (2022) Vol. 24, Iss. 11, pp. 2120-2135
Closed Access | Times Cited: 5
Chih-Yi Lin, Chung-Jen Yu, Chun‐Yu Liu, et al.
Clinical & Translational Oncology (2022) Vol. 24, Iss. 11, pp. 2120-2135
Closed Access | Times Cited: 5
Showing 5 citing articles:
Role of UBE2C in Brain Cancer Invasion and Dissemination
Stefani Domentean, Eunice Paisana, Rita Cascão, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15792-15792
Open Access | Times Cited: 9
Stefani Domentean, Eunice Paisana, Rita Cascão, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15792-15792
Open Access | Times Cited: 9
Diverse roles of UBE2T in cancer (Review)
Nengqian Ma, Zhangzhan Li, Jingting Yan, et al.
Oncology Reports (2023) Vol. 49, Iss. 4
Open Access | Times Cited: 6
Nengqian Ma, Zhangzhan Li, Jingting Yan, et al.
Oncology Reports (2023) Vol. 49, Iss. 4
Open Access | Times Cited: 6
The crosstalk between ubiquitination and endocrine therapy
Yidong Ge, Ziqing Zhan, Meng Ye, et al.
Journal of Molecular Medicine (2023) Vol. 101, Iss. 5, pp. 461-486
Closed Access | Times Cited: 2
Yidong Ge, Ziqing Zhan, Meng Ye, et al.
Journal of Molecular Medicine (2023) Vol. 101, Iss. 5, pp. 461-486
Closed Access | Times Cited: 2
Validation of a Disease-Free Survival Prediction Model Using UBE2C and Clinical Indicators in Breast Cancer Patients
Jun Shen, Huanhuan Yan, Congying Yang, et al.
Breast Cancer Targets and Therapy (2023) Vol. Volume 15, pp. 295-310
Open Access | Times Cited: 2
Jun Shen, Huanhuan Yan, Congying Yang, et al.
Breast Cancer Targets and Therapy (2023) Vol. Volume 15, pp. 295-310
Open Access | Times Cited: 2
A ubiquitin–proteasome system-related signature to predict prognosis, immune infiltration, and therapy efficacy for breast cancer
Xiao Liu, Meihuan Wang, Qian Wang, et al.
Immunologic Research (2023) Vol. 72, Iss. 3, pp. 368-382
Closed Access | Times Cited: 2
Xiao Liu, Meihuan Wang, Qian Wang, et al.
Immunologic Research (2023) Vol. 72, Iss. 3, pp. 368-382
Closed Access | Times Cited: 2
